Skip to research content
Public research library
Topic LNC

Lowest net cost standard and book of business comparison

Published findings, original references and room for an evidence-backed challenge.

What the rubric looks for

Formulary decisions must meet a lowest net cost standard for this plan, the PBM delivers an annual comparison against its whole book of business, and any drug placed above a cheaper equivalent is disclosed with the reason.

Why it matters

Rebate driven formularies can favor a high list price drug that returns more rebate but costs the plan more after the rebate. A stated standard and a book of business comparison make that trade visible.

LNC · Weight 3/100 · Introduced in rubric v2

Reference: Section 6

Only the selected record is loaded. Findings below are not a cross-contract tally or community activity.

Published evidence

Travis County · Envision Pharmaceutical Services, LLC

Published Commons finding

Not addressedFinding rubric version not recorded

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. All five models reached this verdict. There is no lowest net cost standard for formulary decisions and no annual comparison against Envision's whole book of business anywhere in the 18 pages. The claim repricing described on pages 10 and 17 was a one time procurement exercise, not an ongoing contractual standard, and nothing requires disclosure when a drug is placed above a cheaper equivalent. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Inspect historical council readings (5 recorded for this criterion)

These are separately attributed readings of this record, not independent community contributions. Versions can differ; no new consensus has been calculated.

Claude Opus 5

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. There is no lowest net cost standard for formulary decisions and no annual comparison against Envision's whole book of business anywhere in the 18 pages. The consultant notes on page 17 discuss claim repricing done during the bid evaluation, which is a one time procurement exercise rather than an ongoing contractual standard. Nothing requires disclosure when a drug is placed above a cheaper equivalent.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Gemini 3.1 Pro

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The agenda backup does not address lowest net cost standards or book of business comparisons.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

GPT 5.6 Sol

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The formulary discussion on page 10 does not require decisions based on lowest net cost for Travis County. Pages 8 to 11 also contain no annual comparison with Envision's full book of business and no disclosure duty when a drug is placed above a cheaper equivalent. The executed agreement is not available to supply these standards.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Grok 4.6

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. No lowest-net-cost standard, book of business comparison, or disclosure of drugs placed above a cheaper equivalent appears on pages 8 through 11 or 16 through 18. Formulary is mentioned only as Envision flexibility on pages 2 and 10. The executed agreement is not in the file.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Kimi K3

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. No page states a lowest net cost standard for formulary decisions, an annual comparison against the PBM's book of business, or disclosure when a drug is placed above a cheaper equivalent. The entire subject is absent from the backup and would live in the executed agreement.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Document manifest and citation limits

Quotations and rationales are reproduced from published findings, not newly verified here. Named exhibits, amendments and ambiguous references must be checked in the document itself.

Community participation

Have contrary evidence, a missing exhibit or a question about the interpretation? Use the existing community composer to prepare a labelled finding. Publishing a community post is separate from a Commons review and does not change the contract score.

This research topic is not a membership channel. Following topics and private agency workspaces are not enabled here.

PBM Commons · by BetterBuy RxEvidence is public. Interpretation is open to review.

Commons navigation

Find a public record